<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-O12</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-O12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>The do&#x02019;s and dont&#x02019;s of liver CT and MR imaging</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Schima</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>wolfgang.schima@khgh.at</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Diagnostic and Interventional Radiology, Krankenhaus Goettlicher Heiland, KH der Barmherzigen Schwestern, and Sankt Josef-Krankenhaus, Vinzenzgruppe, Dornbacher Strasse 20-28, 1170 Vienna, Austria</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>O12</fpage><lpage>O12</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Schima; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Schima; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/O12"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title/><p>Contrast enhanced multi-detector CT (MD CT) is now the most commonly used imaging modality for detection of liver metastases and work-up of equivocal lesions found at ultrasound. MR imaging is an established technique for non-invasive characterisation of liver masses and for preoperative potentially resectable liver tumours. Diagnostic value of each modality strongly depends on the scan technique. With MDCT, the role of thin slice imaging has been well established, with slice thicknesses of 5&#x02013;7.5 mm being inferior to thinner slices in terms of lesion detection [<xref ref-type="bibr" rid="B1">1</xref>]. The amount of contrast material as well as the flow rate influence enhancement of hypervascular lesions in the arterial phase and the magnitude of liver parenchyma enhancement in the venous phase, respectively [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. The number of CT scans varies with the local indication, with single-phasic venous scans to 4-phasic scans, as recommended by European and US guidelines for HCC detection and characterisation.</p><p>For MR imaging, a multi-point DIXON technique has replaced conventional T1-weighted GRE pulse sequences; with this technique in one breathhold in-phase, opposed-phase, fat-suppressed, and water-suppressed images can be obtained, without any spatial misregistration. Diffusion-weighted pulse sequences significantly improve detection of metastases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. As a black-blood technique with T2-weighted image impression, it demonstrates small lesions without any blurring by an adjacent high signal intensity of vessels of bile ducts [<xref ref-type="bibr" rid="B6">6</xref>]. Administration of contrast agents is mandatory for liver MRI, with the choice of either non-specific gadolinium chelates or liver specific contrast agents. Indications for liver-specific contrast agents include preoperative evaluation of liver metastases and characterisation of hepatocellular lesions (FNH, adenoma), whereas non-specific gadolinium chelates are used for characterisation of haemangiomas, after liver resection or tumour ablation. The choice of the imaging techniques and the scan or contrast agent protocol should be tailored according to the clinical question.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Weg</surname><given-names>N</given-names></name><name><surname>Scheer</surname><given-names>MR</given-names></name><name><surname>Gabor</surname><given-names>MP</given-names></name><article-title>Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation</article-title><source>Radiology</source><year>1998</year><volume>209</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1148/radiology.209.2.9807568</pub-id><?supplied-pmid 9807568?><pub-id pub-id-type="pmid">9807568</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>JK</given-names></name><name><surname>Choi</surname><given-names>BI</given-names></name><name><surname>Kim</surname><given-names>AY</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><article-title>Contrast media in abdominal computed tomography: optimization of delivery methods</article-title><source>Korean J Radiol</source><year>2001</year><volume>2</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.3348/kjr.2001.2.1.28</pub-id><?supplied-pmid 11752966?><pub-id pub-id-type="pmid">11752966</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>PT</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name><article-title>IV contrast selection for MDCT: current thoughts and practice</article-title><source>AJR Am J Roentgenol</source><year>2006</year><volume>186</volume><fpage>406</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.2214/AJR.04.1902</pub-id><?supplied-pmid 16423946?><pub-id pub-id-type="pmid">16423946</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Holzapfel</surname><given-names>K</given-names></name><name><surname>Reiser-Erkan</surname><given-names>C</given-names></name><name><surname>Fingerle</surname><given-names>AA</given-names></name><etal/><article-title>Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer</article-title><source>Abdom Imaging</source><year>2011</year><volume>36</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1007/s00261-010-9633-5</pub-id><?supplied-pmid 20563868?><pub-id pub-id-type="pmid">20563868</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Koh</surname><given-names>DM</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Riddell</surname><given-names>AM</given-names></name><etal/><article-title>Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI)alone and in combination</article-title><source>Eur Radiol</source><year>2008</year><volume>18</volume><fpage>903</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1007/s00330-007-0847-z</pub-id><?supplied-pmid 18193234?><pub-id pub-id-type="pmid">18193234</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Parikh</surname><given-names>T</given-names></name><name><surname>Drew</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>VS</given-names></name><etal/><article-title>Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging</article-title><source>Radiology</source><year>2008</year><volume>246</volume><fpage>812</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1148/radiol.2463070432</pub-id><?supplied-pmid 18223123?><pub-id pub-id-type="pmid">18223123</pub-id></mixed-citation></ref></ref-list></back></article>
